Pacific Biosciences Of California Shares Outstanding 2010-2023 | PACB
Pacific Biosciences Of California shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Pacific Biosciences Of California Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 254 |
| 2022 | 225 |
| 2021 | 204 |
| 2020 | 175 |
| 2019 | 153 |
| 2018 | 135 |
| 2017 | 106 |
| 2016 | 89 |
| 2015 | 76 |
| 2014 | 70 |
| 2013 | 63 |
| 2012 | 56 |
| 2011 | 54 |
| 2010 | 10 |
| 2009 | 1 |
| Pacific Biosciences Of California Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 254 |
| 2023-09-30 | 255 |
| 2023-06-30 | 250 |
| 2023-03-31 | 242 |
| 2022-12-31 | 225 |
| 2022-09-30 | 225 |
| 2022-06-30 | 224 |
| 2022-03-31 | 222 |
| 2021-12-31 | 204 |
| 2021-09-30 | 215 |
| 2021-06-30 | 199 |
| 2021-03-31 | 195 |
| 2020-12-31 | 175 |
| 2020-09-30 | 167 |
| 2020-06-30 | 154 |
| 2020-03-31 | 156 |
| 2019-12-31 | 153 |
| 2019-09-30 | 153 |
| 2019-06-30 | 153 |
| 2019-03-31 | 151 |
| 2018-12-31 | 135 |
| 2018-09-30 | 135 |
| 2018-06-30 | 132 |
| 2018-03-31 | 124 |
| 2017-12-31 | 106 |
| 2017-09-30 | 116 |
| 2017-06-30 | 97 |
| 2017-03-31 | 93 |
| 2016-12-31 | 89 |
| 2016-09-30 | 92 |
| 2016-06-30 | 88 |
| 2016-03-31 | 84 |
| 2015-12-31 | 76 |
| 2015-09-30 | 80 |
| 2015-06-30 | 75 |
| 2015-03-31 | 74 |
| 2014-12-31 | 70 |
| 2014-09-30 | 71 |
| 2014-06-30 | 71 |
| 2014-03-31 | 68 |
| 2013-12-31 | 63 |
| 2013-09-30 | 66 |
| 2013-06-30 | 62 |
| 2013-03-31 | 57 |
| 2012-12-31 | 56 |
| 2012-09-30 | 56 |
| 2012-06-30 | 56 |
| 2012-03-31 | 55 |
| 2011-12-31 | 54 |
| 2011-09-30 | 54 |
| 2011-06-30 | 53 |
| 2011-03-31 | 53 |
| 2010-12-31 | 10 |
| 2010-09-30 | 1 |
| 2010-06-30 | 1 |
| 2010-03-31 | 1 |
| 2009-12-31 | |
| 2009-09-30 | 1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.584B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.656B | 27.71 |
| Intuitive Surgical (ISRG) | United States | $141.664B | 85.34 |
| Edwards Lifesciences (EW) | United States | $54.330B | 35.36 |
| DexCom (DXCM) | United States | $51.584B | 78.14 |
| IDEXX Laboratories (IDXX) | United States | $45.302B | 53.10 |
| Alcon (ALC) | Switzerland | $44.364B | 31.79 |
| IQVIA Holdings (IQV) | United States | $42.578B | 24.70 |
| STERIS (STE) | Ireland | $23.267B | 27.19 |
| Waters (WAT) | United States | $21.461B | 31.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
| Hologic (HOLX) | United States | $17.471B | 19.55 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.151B | 15.35 |
| ShockWave Medical (SWAV) | United States | $12.422B | 77.31 |
| Sysmex ADR (SSMXY) | Japan | $11.022B | 34.56 |
| Teleflex (TFX) | United States | $10.353B | 16.11 |
| Globus Medical (GMED) | United States | $8.736B | 25.61 |
| Penumbra (PEN) | United States | $7.935B | 90.18 |
| Masimo (MASI) | United States | $6.166B | 35.52 |
| Glaukos (GKOS) | United States | $5.610B | 0.00 |
| TransMedics (TMDX) | United States | $4.484B | 425.44 |
| Integer Holdings (ITGR) | United States | $3.944B | 23.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.558B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.422B | 20.32 |
| Tandem Diabetes Care (TNDM) | United States | $3.060B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.923B | 20.05 |
| Inari Medical (NARI) | United States | $2.732B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 20.53 |
| RxSight (RXST) | United States | $2.378B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.086B | 9.10 |
| Veracyte (VCYT) | United States | $1.800B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Artivion (AORT) | United States | $0.990B | 94.92 |
| OPKO Health (OPK) | United States | $0.941B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.88 |
| Silk Road Medical (SILK) | United States | $0.854B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.748B | 0.00 |
| Paragon 28 (FNA) | United States | $0.672B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.640B | 21.72 |
| SiBone (SIBN) | United States | $0.623B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| IRadimed (IRMD) | United States | $0.534B | 29.89 |
| Pulse Biosciences (PLSE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.388B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 11.13 |
| Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
| AxoGen (AXGN) | United States | $0.260B | 0.00 |
| NeuroPace (NPCE) | United States | $0.260B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.202B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.200B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.167B | 8.49 |
| Yubo Biotech (YBGJ) | China | $0.109B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 21.17 |
| Neuronetics (STIM) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.055B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.051B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |